Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.07% to 10729.78, DAX (0.85%) to 25818.21, CAC40 (0.01%) to 7969.42, STOXX 600 (0.36%) to 646.75

Oct 30 ,2026

  • Synopsis:

    • European equity markets ended mixed to mostly lower. Spain and Italy worst performers, with the FTSE MIB and IBEX both closing down ~(1%). Stoxx 600 still on course for decent gains on the week. US equities lower in Friday midday trading, not far from worst levels. Follows a mixed performance for stocks on Thursday. Another day of notable tech weakness to close an up-and-down week, with latest earnings disappointments in view. AI takeaways from AMZN largely upbeat, though expectations elevated and FCF headwinds from outsized capex still an overhang. Slowdown in non-AI segments another key area of scrutiny (similar to GOOGL). INTC results also play into the positive AI compute/capex demand narrative, though margin pressure (and PC headwinds) from memory cost surge and supply constraints receiving bulk of the attention. No help from weaker reports at RDDT, TWLO, and RBLX.

    • Recent selloff across megacap tech, semis a growing overhang for further AI capex, capital raises. Bloomberg noted Alphabet shares now 22% below its $85B June equity offering price, Intel down 33% from its $23B August equity offer, while shareholders who participated in Meta's $25B offering Monday already more than 2% underwater. Fresh equity digestion headwinds arrive ahead of Anthropic's expected November IPO, which could exceed SpaceX for largest debut in history. Pre-IPO perpetual contracts of Anthropic on Hyperliquid are trading at their lowest levels since listing in mid-August, down ~25% from their 9-Sep peak.

    • Oil gained, with WTI crude more than 2% higher above $104/bbl. Brent above $113/bbl. No change on Middle East dynamics. Reports said US military has presented Trump with options for renewed strikes on Iran. Tehran said diplomatic progress depends on acceptance of seven conditions. Oil has moved higher on the potential for renewed US military action.

    • Gold at new YTD lows well below $4000. Industrial metals mixed. Bitcoin lower. Attention on cryptocurrency after suspected hack at Binance, prompting it to freeze $3B in assets while Tether and Circle froze $2.5B in stablecoins.

    • Another heavy earnings calendar to digest in Europe. AI-capex fears from Intel and Amazon impacting EU Tech sector. Banks lower on mixed results and cautious France view from ACA.FP, adjusted PBT miss from NWG.LN although CABK.SM Q3 net profit beat consensus by 8%. Strength in defensives largely earnings-driven on Sanofi (SAN.FP) Q3 beat and outlook upgrade, AstraZeneca (AZN.LN) Q3 beat and $1.5B savings plan, Bayer (BAYN.GR) Roundup court trial win. Media outperformed on UMG.NA earnings beat.

    • Investors continue to digest central bank policy after key meetings this week. ECB takeaways highlight likelihood of December rate hike unless there is a notable deterioration in growth outlook. Source reports also signalled December tightening and then a pause. BoJ on hold via an 8-1 vote, as expected. Outlook Report declared underlying inflation has effectively reached 2% target. Repeated upside risks to inflation from Middle East conflict, AI demand and weak yen. Market prices in 80% chance of a December hike.

    • Heavy data calendar at month-end. Eurozone Q3 beat expectations after mixed national updates, which saw French and Italian data miss, but German, Dutch and Austrian readings beat and Spain met expectations. ECB surveys see professional forecasters revising up headline and core inflation in the near-term; non-financial firms point to ongoing growth in Q3 and unchanged momentum in Q4. German jobless claims increased modestly, as expected.

    • In the UK, latest public inflation expectations number from Citi/YouGov eased in October, but unlikely to change November rate hike expectations. Lloyds Bank business confidence barometer improved after last month's sharp decline, with six-point gain. Nationwide house price measure was flat. Monthly BoE DMP survey and BoE Agents report saw increase in inflation expectations, but no sign of pass-through into wages. Meanwhile, more skepticism over UK Budget plans.

    • The week ahead sees clocks go back in the USA, OPEC+ meeting, interest rate decisions by BOE and Norges Bank amongst others, Oct manufacturing/services PMIs from across the region as well as earnings/updates from ArcelorMittal (MT.NA), Bayer (BAYN.GR), BT Group (BT.A.LN), DHL Group (DHL.GR), Diageo (DGE.LN), Leonardo (LDO.IM), Maersk (MAERSK.B.DC), Novo Nordisk (NOVO.B.DC), Prudential (PRU.LN), Ryanair Holdings (RYA.ID) and Swiss Re (SREN.SW). Of note, US clocks go back 1 hour at 2:00 (local time) on Sun (1st) and there are the Midterm Congressional elections on Tue, the same day as stock exchange closed in Japan for a public holiday. Realistically, if UK PM Burnham is to call a snap general election to be held this year, an announcement will be required this week.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Food & Beverage +2.40%, Health Care +2.30%, Persnl & HHold Goods +1.74%, Media +1.63%, Chemicals +1.05%, Insurance +0.57%, Telecom +0.49%, Real Estate +0.44%, Retail +0.19%, Financial Svcs (0.01%), Utilities (0.12%), Oil & Gas (0.17%), Travel & Leisure (0.28%), Construct & Mtls (0.33%)

      • Underperformers:

        • Basic Resources (2.75%), Technology (2.73%), Banks (2.31%), Ind Goods & Svcs (1.50%), Autos & Parts (0.61%)

    • Macro/politics

      • US tech stocks tumble as earnings stoke AI spending fears (FT )

      • Commission takes a key step forward on 2027 financial support for Ukraine -- link

      • Economy minister warns France could 'hit the wall' as new figures show GDP contraction (POLITICO)

      • Protesters clash with police in Rome, Turin and Vicenza (ANSA )

    • Company news:

      • Notable Gainers

        • +12.1% PROX.BB (Proximus €6.23, +0.67) -- Q3 earnings

        • +11.7% MCG.LN (Mobico Group £0.44, +0.05) -- Autobuses de León, S.L. cash offer at 46p/ Mobico sh

        • +8.8% XBRANE.SS (Xbrane Biopharma SEK14.15, +1.15) -- Q3 earnings

        • +7.2% AZN.LN (AstraZeneca £139.98, +9.46) -- Q3 earnings, initiates Reshaping for Sustainable Growth programme

        • +6.7% BT.A.LN (BT Group £2.27, +0.14) -- Virgin Media O2 approaching deal to use BT's broadband network - FT

        • +6.0% AEDAS.SM (AEDAS Homes €23.75, +1.35) -- Neinor Homes cash offer at €24.0/ AEDAS Homes share

        • +5.9% PUM.GR (Puma €26.69, +1.48) -- Q3 revenue

        • +5.8% ANORA.FH (Anora Group €4.19, +0.23) -- Q3 earnings

        • +5.8% SCR.FP (SCOR SE €34.92, +1.90) -- Q3 earnings

        • +5.6% CRBN.NA (Corbion €27.37, +1.45) -- Barclays upgrade

        • +5.2% SAN.FP (Sanofi €80.08, +3.93) -- Q3 earnings

        • +4.7% BAYN.GR (Bayer AG €50.22, +2.26) -- US Court ruling in first Roundup trial

        • +4.3% BONHR.NO (Bonheur NOK265.00, +11.00) -- Q3 earnings

        • +3.9% CARL.B.DC (Carlsberg DKK971.00, +36.80)

        • +3.8% EL.FP (EssilorLuxottica €184.95, +6.75) -- Czech billionaire Strnad offers €30B for EssilorLuxottica shareholder Delfin -- Reuters, il Domani

        • +3.1% LOOMIS.SS (Loomis SEK557.00, +17.00) -- Q3 earnings

        • +2.4% KMR.LN (Kenmare Resources £2.38, +0.06) -- renewal of key rights and concessions pursuant to Moma's Implementation agreement until 2044 in Mozambique

        • +2.4% WKL.NA (Wolters Kluwer €86.76, +2.06) -- divests German consumer tax business for €40M

        • +1.5% GXI.GR (Gerresheimer €32.38, +0.48) -- prelim. Q3 earnings

        • +1.4% QLINEA.SS (Q-linea SEK14.90, +0.20) -- Q3 earnings

        • +0.7% DOC.AV (DO & CO €208.00, +1.50) -- initiated buy at UBS

      • Notable Decliners

        • -15.2% AMP.IM (Amplifon €11.08, -1.99) -- Q3 earnings

        • -11.9% IQE.LN (IQE £0.34, -0.05) -- Atomera (ATOM) results

        • -10.5% JLP.LN (Jubilee Metals Group £0.02, -0.00)

        • -9.4% AKTIA.FH (Aktia Bank €11.14, -1.16) -- Q3 earnings

        • -9.3% ETL.FP (Eutelsat Communications €1.82, -0.19) -- Q1 revenue

        • -8.9% LPK.GR (LPKF Laser & Electronics €10.20, -1.00)

        • -8.6% NWG.LN (NatWest Group £5.80, -0.55) -- Q3 earnings

        • -8.3% GMM.GR (Grammer €9.35, -0.85) -- final Q3 earnings

        • EU tech sector

          • -8.0% ASM.NA (ASM International €726.80, -62.80)

          • -6.7% IFX.GR (Infineon Technologies €50.40, -3.61)

          • -6.2% ASML.NA (ASML Holding €1,411.40, -93.40)

        • -5.5% AAF.LN (Airtel Africa £2.59, -0.15) -- H1 earnings

        • -5.0% ECMPA.NA (Eurocommercial Properties €24.70, -1.30) -- 9M earnings; acquires Les Grands Prés, in Belgium and places 5.2M new shares at €24.70/sh, resulting in €128.4M gross proceeds

        • -4.6% ACX.SM (Acerinox €16.22, -0.78) -- Q3 earnings

        • -3.6% YIT.FH (Yit €3.86, -0.15) -- Q3 earnings

        • -3.2% ALCOX.FP (Nicox €0.30, -0.01) -- H1 earnings

        • -2.9% VLK.NA (Van Lanschot Kempen €61.90, -1.85) -- 9M trading update

        • -2.8% BITTI.FH (Bittium €38.60, -1.10) -- OP Corporate Bank downgrade

        • -2.2% STERV.FH (Stora Enso €9.54, -0.21) -- Q3 earnings; approves Bergslagets Skogar demerger plan; announces strategic targets and dividend policy

        • -2.1% SLP.LN (Sylvania Platinum £0.84, -0.02) -- Q1 earnings

        • -2.1% TPEIR.GA (Piraeus Bank €9.80, -0.21) -- Q3 earnings

        • -1.5% FUR.NA (Fugro €7.95, -0.12) -- Q3 revenue

        • -0.3% ADOC.FP (Adocia €3.05, -0.01) -- Q3 revenue

    • EU companies reporting Monday:

      • Earnings:

        • DACHs: AdvancedAdvT (06P0.GR), Amadeus FiRe (AAD.GR)

        • France: Coface (COFA.FP)

        • Nordics: Bakkafrost (BAKKA.NO), AcadeMedia (ACAD.SS), Framery Group (FRAMERY.FH), Aspo (ASPO.FH), Ilkka (ILKKA.FH)

        • Southern Europe: Lottomatica Group (LTMC.IM), Grifols (GRF.SM), Corticeira Amorim (COR.PL)

        • Other: Ryanair Holdings (RYA.ID)

      • Trading Update:

        • France: Forvia (FRVIA.FP)

      • CMD/Events: Kalmar (KALMAR.FH), Grupo Ezentis (EZE.SM) EGM, Saniona (SANION.SS) EGM, Gentoo Media (G2M.SS) EGM

  • Data:

    • Economics:

      • Q3 Preliminary GDP

        • Finland +1.8% y/y vs consensus +2.0% and prior +1.6%

        • France (0.1%) y/y vs consensus +0.3% and prior +0.5%

        • Austria +0.6% y/y vs consensus +0.2% and prior +0.4%

        • Spain +2.7% y/y vs consensus +2.7% and prior +2.6%

        • Netherlands +2.1% y/y vs consensus +1.4% and prior +1.6%

        • Germany +1.2% y/y vs consensus +1.1% and prior +1.0%

        • Italy +0.8% y/y vs consensus +0.9% and prior +1.0%

        • Portugal +2.4% y/y vs consensus +2.2% and prior +2.5%

      • Oct Preliminary CPI

        • France +3.4% y/y vs consensus +3.2% and prior +3.1%

        • Spain +4.9% y/y vs consensus +4.9% and prior +4.9%

      • France Sep Consumer Spending (0.5%) m/m vs consensus +0.1% and prior (0.5%) (2:30ET)

      • Denmark Sep Unemployment Rate 2.7% vs consensus 2.8% and prior 2.7%

      • Germany Oct Unemployment Change +4K vs consensus +5K and prior +12K

      • UK Oct Nationwide House Price Index +0.5% y/y vs consensus +0.6% and prior +0.8%

      • France Sep PPI +6.8% y/y vs consensus +5.4% and prior revised +4.9% from +4.8%

    • Markets:

      • WTI Crude (Dec 26): +$2.18 or +2.14% to $104.18

      • €-$ (0.0023) or (0.21%) to 1.1160

      • £-$ +0.0021 or +0.16% to 1.3397

      • €-£ (0.0027) to 0.8331

      • S&P 500 (1.57%)

      • Performance year-to-date

        • FTSE 100: +8.04%

        • DAX: +5.42%

        • CAC: (2.21%)

        • MIB: +10.14%

        • Stoxx 600: +9.21%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.